Does a parathyroid hormone level of 90 pg/mL with a serum calcium of 8.6 mg/dL and serum magnesium of 1.3 mg/dL indicate secondary hyperparathyroidism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does This Indicate Secondary Hyperparathyroidism?

These laboratory values (PTH 90 pg/mL, calcium 8.6 mg/dL, magnesium 1.3 mg/dL) are consistent with secondary hyperparathyroidism, but you must first rule out correctable causes—particularly low magnesium, vitamin D deficiency, and inadequate calcium intake—before accepting this diagnosis.

Critical First Steps

The low-normal calcium (8.6 mg/dL) with elevated PTH (90 pg/mL) suggests an appropriate PTH response to relative hypocalcemia. However, the magnesium of 1.3 mg/dL is below normal (normal range typically 1.7-2.2 mg/dL), which is a critical finding that must be addressed immediately 1.

Why Magnesium Matters

Hypomagnesemia can cause functional hypoparathyroidism or paradoxically impair PTH secretion and action. You must correct the magnesium deficiency first, as this alone may normalize the PTH elevation.

Diagnostic Algorithm

Before confirming secondary hyperparathyroidism, systematically exclude these causes:

  1. Correct magnesium deficiency - Supplement to achieve normal levels (>1.7 mg/dL)

  2. Check 25-hydroxyvitamin D levels - Must be >30 ng/mL and maintained for >6 months 1

    • If deficient, supplement with cholecalciferol or ergocalciferol
    • Recheck PTH only after sustained vitamin D repletion
  3. Assess calcium intake - This is an underrecognized cause of PTH elevation 2, 3

    • Implement a calcium challenge: 600 mg calcium twice daily for 2-3 weeks
    • Recent evidence shows ~50-55% of patients with normocalcemic PTH elevation have secondary hyperparathyroidism due to insufficient calcium intake 2, 3
    • Recheck PTH after supplementation; normalization confirms dietary calcium deficiency as the cause
  4. Evaluate renal function - Calculate eGFR to assess for chronic kidney disease 4

    • Even mild CKD (Stage 3, GFR <60 mL/min/1.73m²) commonly causes secondary hyperparathyroidism
  5. Review medications - Loop diuretics increase urinary calcium losses 2

  6. Consider malabsorption - History of bariatric surgery (gastric bypass, sleeve gastrectomy) or gastrointestinal disorders 2

Interpretation Framework

According to the 2025 French consensus, secondary hyperparathyroidism is characterized by elevated PTH with normal or low calcium levels, but only after excluding reversible causes 1. The decision tree emphasizes:

  • PTH elevated + Calcium normal or low → Rule out causes of secondary hyperparathyroidism
  • This includes vitamin D deficiency, renal insufficiency, calcium malabsorption, and inadequate intake

Common Pitfalls to Avoid

  1. Don't accept the diagnosis prematurely - The most frequent error is failing to correct magnesium, vitamin D, and calcium intake before labeling this as secondary hyperparathyroidism

  2. Don't ignore the magnesium - At 1.3 mg/dL, this is significantly low and must be corrected first

  3. Don't check PTH too soon after supplementation - Allow adequate time (2-3 weeks for calcium challenge, >6 months for vitamin D normalization) before rechecking 1

  4. Don't assume dietary intake is adequate - Even in developed countries, insufficient calcium intake is a common cause of elevated PTH with normal calcium 2, 3

Management After Excluding Reversible Causes

If PTH remains elevated after correcting magnesium, ensuring adequate vitamin D (>30 ng/mL for >6 months), completing a calcium challenge, and ruling out renal insufficiency, then true secondary hyperparathyroidism is confirmed.

For CKD-related secondary hyperparathyroidism (if eGFR <60):

  • Target PTH ranges vary by CKD stage 4
  • Stage 3 CKD: Consider active vitamin D therapy (calcitriol 0.25 μg/day or alfacalcidol 0.25-0.5 μg/day) if PTH remains elevated 4
  • Monitor calcium and phosphorus monthly initially, then every 3 months 4

The bottom line: This biochemical pattern suggests secondary hyperparathyroidism, but the low magnesium and relatively low-normal calcium demand immediate attention to reversible causes before confirming the diagnosis and initiating specific treatment.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.